{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:03:44Z","timestamp":1792451024504,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":383,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003331","name":"Provincial Health Services Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jacc.2019.07.035","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T15:40:28Z","timestamp":1568043628000},"page":"1444-1450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Oral Fluoroquinolones and Risk\u00a0of\u00a0Mitral\u00a0and Aortic Regurgitation"],"prefix":"10.1016","volume":"74","author":[{"given":"Mahyar","family":"Etminan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Sodhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Ganjizadeh-Zavareh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Carleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Kezouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Brophy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2019.07.035_bib1","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2012.383","article-title":"Oral fluoroquinolones and the risk of retinal detachment","volume":"307","author":"Forooghian","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.07.035_bib2","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/jama.2013.280500","article-title":"Association between oral fluoroquinolone use and retinal detachment","volume":"310","author":"Pasternak","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.07.035_bib3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jac\/dku507","article-title":"Association between oral fluoroquinolone use and the development of retinal detachment: a systematic review and meta-analysis of observational studies","volume":"70","author":"Chui","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jacc.2019.07.035_bib4","doi-asserted-by":"crossref","first-page":"k678","DOI":"10.1136\/bmj.k678","article-title":"Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study","volume":"360","author":"Pasternak","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.07.035_bib5","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/jamainternmed.2015.5389","article-title":"Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone","volume":"175","author":"Lee","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2019.07.035_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010077","article-title":"Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study","volume":"5","author":"Daneman","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2019.07.035_bib7","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/WNL.0000000000000846","article-title":"Oral fluoroquinolone use and risk of peripheral neuropathy: A pharmacoepidemiologic study","volume":"83","author":"Etminan","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2019.07.035_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.0887","article-title":"Association between peripheral neuropathy and exposure to oral fluoroquinolone or amoxicillin-clavulanate therapy","author":"Morales","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jacc.2019.07.035_bib9","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/cid\/cis664","article-title":"Fluoroquinolones and the risk of serious arrhythmia: a population-based study","volume":"55","author":"Lapi","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2019.07.035_bib10","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.resuscitation.2019.04.030","article-title":"Fluoroquinolone use and serious arrhythmias: a nationwide case-crossover study","volume":"139","author":"Porta","year":"2019","journal-title":"Resuscitation"},{"key":"10.1016\/j.jacc.2019.07.035_bib11","article-title":"Fluoroquinolones increase the risk of serious arrhythmias: a systematic review and meta-analysis","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacc.2019.07.035_bib12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1124\/jpet.103.057984","article-title":"In\u00a0vitro discrimination of fluoroquinolones toxicity on tendon cells: involvement of oxidative stress","volume":"308","author":"Pouzaud","year":"2003","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jacc.2019.07.035_bib13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/jor.21576","article-title":"The effect of aging on migration, proliferation, and collagen expression of tenocytes in response to ciprofloxacin","volume":"30","author":"Chang","year":"2012","journal-title":"J\u00a0Orthop Res"},{"key":"10.1016\/j.jacc.2019.07.035_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jor.21196","article-title":"Ciprofloxacin up-regulates tendon cells to express matrix metalloproteinase-2 with degradation of type I collagen","volume":"29","author":"Tsai","year":"2011","journal-title":"J\u00a0Orthop Res"},{"key":"10.1016\/j.jacc.2019.07.035_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mehy.2018.09.013","article-title":"Ciprofloxacin and acute aortic valve damage","volume":"121","author":"Schj\u00f8tt","year":"2018","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jacc.2019.07.035_bib16","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1172\/JCI23701","article-title":"Marfan syndrome and mitral valve prolapse","volume":"114","author":"Weyman","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2019.07.035_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199907013410101","article-title":"Prevalence and clinical outcome of mitral-valve prolapse","volume":"341","author":"Freed","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.07.035_bib18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCULATIONAHA.115.016291","article-title":"Arrhythmic mitral valve prolapse and sudden cardiac death","volume":"132","author":"Basso","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.07.035_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157753","article-title":"OpenVigil FDA\u2013Inspection of U.S. American adverse drug events pharmacovigilance data and novel clinical applications","volume":"11","author":"B\u00f6hm","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2019.07.035_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nbt.2113","article-title":"OpenVigil\u2013free eyeballs on AERS pharmacovigilance data","volume":"30","author":"B\u00f6hm","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jacc.2019.07.035_bib22","doi-asserted-by":"crossref","first-page":"k3532","DOI":"10.1136\/bmj.k3532","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.07.035_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0002-8703(03)00512-X","article-title":"The nested case-control study in cardiology","volume":"146","author":"Essebag","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2019.07.035_bib25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.07.035_bib27","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3122\/jabfm.16.5.458","article-title":"Levofloxacin-induced tendon rupture: a case report and review of the literature","volume":"16","author":"Gold","year":"2003","journal-title":"J Am Board Fam Pract"},{"key":"10.1016\/j.jacc.2019.07.035_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2005.11.034","article-title":"Type I and type III collagen synthesis and composition in the valve matrix in aortic valve stenosis","volume":"189","author":"Eriksen","year":"2006","journal-title":"Atherosclerosis"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719359789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719359789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:23:50Z","timestamp":1760016230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109719359789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0735109719359789"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2019.07.035","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Fluoroquinolones and Risk\u00a0of\u00a0Mitral\u00a0and Aortic Regurgitation","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2019.07.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}